Adcentrx Therapeutics
Signal active
Organization
Contact Information
Overview
Adcentrx is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By combining the targeting precision of biologics and the disease fighting power of small molecule payloads, Adcentrx strives to develop next generation targeted therapies for improving patient treatment options.
About
Industries
Biotechnology, Pharmaceutical
Founded
2021
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Adcentrx Therapeutics headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical sector. The company focuses on Biotechnology and has secured $1.6B in funding across 16 round(s). With a team of 11-50 employees, Adcentrx Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Adcentrx Therapeutics, raised $50.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
3
Lead Investors
0
Total Funding Amount
$101.0M
Details
2
Adcentrx Therapeutics has raised a total of $101.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Early Stage Venture | 51.0M | ||
| 2021 | Early Stage Venture | 50.0M |
Investors
Adcentrx Therapeutics is funded by 17 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| C-Bridge Capital | - | FUNDING ROUND - C-Bridge Capital | 50.0M |
| Zoo Capital | - | FUNDING ROUND - Zoo Capital | 50.0M |
| Adcentrx Therapeutics | - | FUNDING ROUND - Adcentrx Therapeutics | 50.0M |
| CBC Group | - | FUNDING ROUND - CBC Group | 50.0M |
Recent Activity
There is no recent news or activity for this profile.